Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
11/18/2009 | EP2119728A1 Therapeutic and diagnostic agents |
11/18/2009 | EP2119726A1 Novel and powerful MHC-class II peptides derived from survivin and neurocan |
11/18/2009 | EP2119453A1 Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of b-chronic lymphocytic leukaemia |
11/18/2009 | EP2119452A1 Pharmaceutical composition, comprising an anti-cd6 monoclonal antibody used in the diagnosis and treatment of rheumatoid arthritis |
11/18/2009 | EP2118668A1 Method of determining nt-probnp |
11/18/2009 | EP2118300A2 Prevention and treatment of synucleinopathic and amyloidogenic disease |
11/18/2009 | EP2118142A2 Humaneered anti-factor b antibody |
11/18/2009 | EP2118141A2 Monoclonal antibodies that neutralize anthrax toxins |
11/18/2009 | EP2118140A2 Human cytomegalovirus neutralising antibodies and use thereof |
11/18/2009 | EP2118139A1 Antibodies specific for varicella zoster virus |
11/18/2009 | EP2118138A1 Sequence based engineering and optimization of single chain antibodies |
11/18/2009 | EP2117594A2 Pharmaceutical composition containing antibodies directed against the herv-w envelope |
11/18/2009 | EP2117593A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
11/18/2009 | EP2117575A2 Methods and compositions related to clot binding compounds |
11/18/2009 | EP2117571A2 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof |
11/18/2009 | EP1817345B9 Antibodies against tenascin-c |
11/18/2009 | EP1543122B1 Bitter taste receptors |
11/18/2009 | EP1451552B1 Reagents and methods useful for detecting diseases of the breast |
11/18/2009 | EP1332214B1 32144, a human fatty acid amide hydrolase and uses thereof |
11/18/2009 | EP1317548B1 Transglutaminase gene products |
11/18/2009 | EP0914422B1 Mammalian genes involved in viral infection |
11/18/2009 | EP0758904B1 Methods and compositions for the treatment of glomerulonephritis |
11/18/2009 | CN101583715A Inhibitory polynucleotide compositions and methods for treating cancer |
11/18/2009 | CN101583627A Methods for reducing phosphate absorption |
11/18/2009 | CN101583626A Anti-CD20 antibodies and methods of use |
11/18/2009 | CN101583625A Anti-CD16 binding molecules |
11/18/2009 | CN101583624A Compositions and methods for diagnosing and treating cancer |
11/18/2009 | CN101583621A AMIGO-2 inhibitors for treating, diagnosing or detecting cancer |
11/18/2009 | CN101583376A Improved stably tethered structures of defined compositions with multiple functions or binding specificities |
11/18/2009 | CN101580546A Human anti human interferon alpha antibody and application thereof |
11/18/2009 | CN101580545A Monoclonal antibody of hemagglutinin protein resisting H5N1 resource and application thereof |
11/18/2009 | CN101580544A Plate for detecting immunity of cannabis and tetrahydrocannabinol monoclonal antibody through collaurum tag |
11/18/2009 | CN101580542A Application of mycobacterium tuberculosis adhesion HBHA in diagnosing and treating tuberculosis |
11/18/2009 | CN101580538A WT1-origin HLA-DR-binding antigen peptide |
11/18/2009 | CN101580537A Human cytomegalovirus UL 49 gene antigenic peptide, antibody thereof and use thereof |
11/18/2009 | CN101580534A CpTI enzyme-linked immunoassay reagent kit as well as preparation method and application thereof |
11/18/2009 | CN100560723C Recombinant human sCTLA4-Ig fusion protein gene and its medicinal composition |
11/18/2009 | CN100560602C Monoclonal antibody of immunoglobulin of anti lymphocyst vitos of Pacific fluke, and preparation method |
11/18/2009 | CN100560549C Synthesis process of 18F labeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst |
11/18/2009 | CN100560131C Antibody targeting compounds |
11/17/2009 | USRE40988 infections caused by HIV-1 or HIV-2; pain; cancers; anorexia nervosa; bulimia; cachexia; obesity; diabetes; asthma; Parkinson's disease; both acute and congestive heart failure; hypotension; hypertension; urinary retention; osteoporosis; angina pectoris; myocardial infarction; ulcers |
11/17/2009 | US7619078 T cell costimulatory molecule genes; used to identify components of the signal transduction pathway induced in a cell |
11/17/2009 | US7619072 Purifying lectin Concanavalin A (Con A) using a buffer in which impurities, such as glycogen and other substances are soluble, but in which the protein remains insoluble |
11/17/2009 | US7619071 Humanized monoclonal antibody; human cytokine receptors; usefulness in both basic research and as therapeutics |
11/17/2009 | US7619070 Humanized antibodies to interferon alpha receptor-1 (IFNAR-1) |
11/17/2009 | US7619069 Antibodies to TGF-beta 1 |
11/17/2009 | US7619068 Antiovarian, pancreatic, lung or breast cancer antigen (Ovr110) antibodies that internalize upon binding to Ovr110 on a mammalian in vivo; detecting Ovr110 overexpression |
11/17/2009 | US7619065 Cystine-knot fold protein |
11/17/2009 | US7619062 PRO214 polypeptides |
11/17/2009 | US7619057 Cancer antigen peptide and/or major histocompatibility complex binding sites for use as tools in detection and tretment of cell proliferative disorders; immunotherapy; genetic vaccine |
11/17/2009 | US7618937 Macromolecular antifouling chimeric compositions or coatings comprising peptide or polypeptide anchor moiety or component coupled to peptoid or polypeptoid moiety or component; inhibits protein adsorption or cell fouling of surfaces onto which composition is coated; medical devices; inhibits biofouling |
11/17/2009 | US7618791 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
11/17/2009 | US7618783 Anthrax specific antibodies |
11/17/2009 | US7618641 Functionally reconstituted viral membranes containing adjuvant |
11/17/2009 | US7618636 Sequences from the bacterium Neisseria meningitidis. |
11/17/2009 | US7618634 Neurotoxic oligomers |
11/17/2009 | US7618633 Antibodies that bind CD40 and methods of treating cancer and enhancing immune responses |
11/17/2009 | US7618632 Expression vector comprising nucleotide sequences coding glucocorticoid-induced tumor necrosis factor receptor protein (GITR) for use in diagnosis, prevention and treatment of cancer, infection, autoimmune, inflammatory and/or transplant rejection |
11/17/2009 | US7618631 Treating ErbB2-expressing cancer in a human by administering an antibody which binds ErbB2 and comprises variable light (VL) domain and variable heavy (VH) domain amino acid sequences and an antiestrogen; antitumor and antimetastasis agents; side effect reduction |
11/17/2009 | US7618630 Administering to an individual a therapeutically effective amount of an antagonist of an interaction between an alpha 4 subunit-bearing integrin and a ligand for an alpha 4 subunit-bearing integrin |
11/17/2009 | US7618629 Manipulation of cytokine levels using CD83 gene products |
11/17/2009 | US7618628 CD16A binding proteins and use for the treatment of immune disorders |
11/17/2009 | US7618627 Monitoring apoptosis in tumor cells by the co-administration of ionizing radiation and an anti-integrin antibody; reducing proliferation of tumor cells |
11/17/2009 | US7618625 Compositions comprising large and small binding fragments of antibodies against the same toxin |
11/17/2009 | CA2400117C Novel collagen-like protein clac, a precursor thereof, and genes encoding the same |
11/17/2009 | CA2360530C A human nuclear protein having a ww domain and a polynucleotide encoding the protein |
11/17/2009 | CA2230949C Synthetic peptides that inhibit il-6 activity |
11/17/2009 | CA2211459C A method for making heteromultimeric polypeptides |
11/17/2009 | CA2157577C Growth differentiation factor-8 |
11/12/2009 | WO2009137631A2 Methods for identifying compounds that affect expression of cancer-related protein isoforms |
11/12/2009 | WO2009137577A2 Leishmania vaccine using sand fly salivary immunogen |
11/12/2009 | WO2009137424A1 Method of preventing the development of rheumatoid arthritis in subjects with undifferentiated arthritis |
11/12/2009 | WO2009137113A2 Peptides, antibodies, and uses thereof for identifying and targeting provasopressin-expressing cancer cells |
11/12/2009 | WO2009137075A1 Anti-activin antibodies and uses for promoting bone growth |
11/12/2009 | WO2009136499A1 Aβ-OLIGOMER MEASUREMENT METHOD |
11/12/2009 | WO2009136373A1 Sub-region of a plasmodium protein with improved vaccine potential, and medical uses thereof |
11/12/2009 | WO2009136286A2 Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof |
11/12/2009 | WO2009136070A1 Novel antibodies used to treat cancer |
11/12/2009 | WO2009136031A1 Use of an anti-cd151 antibody for early treatment of cancer |
11/12/2009 | WO2009135976A1 Method for generating monoclonal antibodies that recognize progenitor cells |
11/12/2009 | WO2009135953A2 Amino acid sequences directed against integrins and uses thereof |
11/12/2009 | WO2009135861A2 Humanized antibodies against human interferon-alpha |
11/12/2009 | WO2009135656A1 A method for the purification of antibodies using displacement chromatography |
11/12/2009 | WO2009135627A1 Use of a radioactively labelled molecule specifically binding to ed-b fibronectin in a method of hodgkin lymphoma |
11/12/2009 | WO2009115508A3 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
11/12/2009 | WO2009114560A3 Compositions and methods for the therapy and diagnosis of cytomegalovirus infections |
11/12/2009 | WO2009109572A3 Monovalent phage display of single variable domains |
11/12/2009 | WO2009087577A3 Barb4 target which comprises tata-binding protein-associated factor 15, antibody designated barb4, barb4 related antibodies, and methods of making and using same |
11/12/2009 | WO2009085200A3 Anti-amyloid antibodies and uses thereof |
11/12/2009 | US20090281285 Binding member which binds to both lewis-y and lewis-b haptens, and its use for treating cancer |
11/12/2009 | US20090281284 utilizes anti-gold antibody; for detection of target substances |
11/12/2009 | US20090281279 Rigidized trimethine cyanine dyes |
11/12/2009 | US20090281277 Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same |
11/12/2009 | US20090281066 Treatment of proliferative disorders with amino-substituted (E)-2,6- dialkoxystyryl 4-substituted benzylsulfones |
11/12/2009 | US20090281044 Elastin digest compositions and methods utilizing same |
11/12/2009 | US20090281035 Soluble Heterodimeric Receptors and Uses Thereof |
11/12/2009 | US20090280560 Yeast cell surface display of proteins and uses thereof |
11/12/2009 | US20090280510 Antibodies Specific to Heterodimers of Bcl-2 Family and Uses Thereof |
11/12/2009 | US20090280508 Methods and Reagents for Preparing and Using Immunological Agents Specific for P-Glycoprotein |
11/12/2009 | US20090280507 Method for measurement of sars virus nucleocapsid protein, reagent kit for the measurement, test device, monoclonal antibody directed against sars virus nucleocapsid protein, and hybridoma capable of producing the monoclonal antibody |